Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative...

36
16:38-16:46 Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire Servien* Philippe Neyret* *Albert Trillat Center- Lyon, France 2 nd Insight – Amsterdam – 6-8 October 2016

Transcript of Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative...

Page 1: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

16:38-16:46Perioperative management :

Preventing 30-day readmissions

Sébastien LUSTIG MD, PhD, Prof *Elvire Servien* Philippe Neyret*

*Albert Trillat Center- Lyon, France

2nd Insight – Amsterdam – 6-8 October 2016

Page 2: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

4.6%

Page 3: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Clinical factors :perioperative transfusion (13% greater risk)

« …» The top 5 most frequently reported primary reasons for 30- or 90-day readmission in TKA were surgery and medical related: wound infection, deep

infection, atrial fibrillation, cellulitis and abscess of leg, or pulmonary embolism « …»

952,593 older patients (65þ) with a primary TKA October 2016

Page 4: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Wound relatedSuperficial Site infectionn°1

Page 5: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Non infectious wound problemsand /or

Bleeding

n°2

Page 6: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Limited motionn°3

Page 7: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Medical Complications n°4

Page 8: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

VTE ?

Reason for readmission :

• limited motion (18.2%), • wound complication (14%), • surgical site infection (9.9%), • bleeding (9.9%).

«…» The cost of bleeding, wound complications, infection, and limited motion each exceeded the cost of VTE. These results challenge the identification of

VTE as a “never event. «…»

n°5

• VTE was less common (3.3%), and all occurred despite adequate prophylaxis.

Page 9: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire
Page 10: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Periprosthetice fracturen°6

Page 11: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Preventing 30-days readmission

« OPTIMIZATION »

PatientSurgery

Perioperative managament

Page 12: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Patient OptimizationModifiable Risk Factors

• 1. Diabetes• 2. Obesity• 3. Malnutrition• 4. Smoking• 5. Mental health• 6. MRSA Screening

Page 13: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

ObesityModifiable

AAHKS 2014

« It is our concensus opinion that consideration should be given to delaying total joint arthroplasty in a patient with a BMI > 40,

especially when associated with other co-morbid conditions, such as poorly controlled diabetes or malnutrition.

Page 14: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Mechanical / Biological

Real problem is biology : Fat degradation products (Leptine Adiponectine ) low grad inflammation status

Page 15: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Superficial wound infectionDeep periprosthetic joint infection

Page 16: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Current smokingModifiable

Systemic effects of smoking and Nicotine

Local Tissue Hypoxia :- micro-vascular constriction- Increase carboxyhemoglobin

Decreased collagen production- Wound healing

Decreased T cell function- Infection

Cochrane Database 2005 – Moeller Lancet 2002

Smoking cessation 4-8 weeks prior surgery

Decrease complications but not normalize

Page 17: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Nasal carriage of staphylococcus Aureus Modifiable

Preop screening MRSA and MSSA

30% population MSSA carriers4% MRSA carriers

Goal : Decrease the incidence of postoperative S aureus SS by eliminating S aureus nasal carriage from the patient prior to surgery

Springer 2014 – Metanalysis 16 studies / 56711 patients

Nasal decolonization resulted in 54,6% decrease in the risk of SSI compared to controls

Page 18: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Blood statusModifiable

Allogenic blood transfusionBlood Loss > 1L

Pulido et al. CORR 2008

Page 19: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

NFS-P-TP-TCABilan martialBilan rénalVit B12 – Folates

J-28

Hb>13g/dlCST > 20%

Hb > 13g/dlCST < 20%

Hb < 13g/dl

Rien Fer IV

Ferritine < 30μg/lCST < 20%

Ferritine 30-100μg/lCST < 20%

Ferritine > 100μg/lCST > 20%

Carence martiale Anémieinflammatoire

EPOFer IV

InsuffisanceRénale chronique

Vit B12 < 200pg/mlFolates < 5 ng/ml

Consultationnéphrologique

Vit B12 250μg/JSpéciafoldine 5mg/J

Hb (g/dl) Injection EPO

10-11 4

11-12 3

12-13 2

Blood managem

ent

strategy is c

rucial +++

Page 20: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

How to prevent 30dys readmission?

Rule n°1

Patient selection

Page 21: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire
Page 22: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Team Work

Page 23: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Length of Hospitalization ?

OUTPATIENT SURGERY ?

No statistical difference for readmission

Page 24: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Clinical Pathway

« … »  guidelines that consider patient-centered care processes « … »

Page 25: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire
Page 26: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Preoperative Surgical Visit

Establish level of risk present

Establish a plan to

mitigate risk

Written comm

unication

Page 27: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Preoperative Preparation

Preoperative Education

Page 28: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Inpatient preparation/ operation

Infection prevention

Thromboembolism prevention

Page 29: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Inpatient stay and discharge process

Early mobilization

Group physical therapy

Checklist before discharge

Page 30: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Post discharge rehabilitation and followup care

Standardised Pathway

Rehabilitation

Wound monitoring

VTE prophylax

is

Page 31: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire
Page 32: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Randomized controlled trials have shown that improvement in the following areas can directly reduce readmission rates:

- quality of care during the initial admission; - improvement in communication with patients, their caregivers, and their clinicians; - patient education; - pre-discharge assessment; - coordination of care after discharge.

Page 33: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Randomized controlled trials have shown that improvement in the following areas can directly reduce readmission rates:

- quality of care during the initial admission; - improvement in communication with patients, their caregivers, and their clinicians; - patient education; - pre-discharge assessment; - coordination of care after discharge.

Page 34: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

« Digital Health Programs »

Page 35: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Take home message

Patient selectionPatient optimizationClinical PathwaysDigital platform ?

Preventing 30-day readmissions

Page 36: Sébastien LUSTIG MD, PhD, Proforthopedie-lyon.fr/wp-content/uploads/2016/12/30... · Perioperative management : Preventing 30-day readmissions Sébastien LUSTIG MD, PhD, Prof * Elvire

Thank [email protected]